Extensive coagulation monitoring in patients after implantation of the MicroMed debakey continuous flow axial pump

ASAIO Journal

Volumn 50, Issue 5, 2004, Pages 424-431

  Bonaros, Nikolaos ^a,b   Mueller, Michael Rolf ^a   Salat, Andreas ^a   Schima, Heinrich ^c   Roethy, Wilfried ^a   Rocher, Alfred A ^d   Wolner, Ernst ^a   Wieselthaler, Georg M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c L Boltzmann Inst Cardiosurg Res   (Austria)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIAGGREGATION THERAPY; BLOOD AGGREGOMETRY; THROMBOGENIC PROPERTIES; VENTRICULAR ASSIST DEVICE (VAD);

AXIAL FLOW; BLOOD; COAGULATION; IMPLANTS (SURGICAL); TRANSPLANTATION (SURGICAL);

CARDIOLOGY;

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBIN III; DIPYRIDAMOLE; HEPARIN; HEPARIN ANTAGONIST; PHENPROCOUMON; PROTAMINE SULFATE; WARFARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TEST; BLOOD FLOW; BLOOD PUMP; CLINICAL ARTICLE; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; FUNCTION TEST; HEMOLYSIS; HUMAN; IMPLANT; MALE; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROTHROMBIN TIME; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY; THROMBOEMBOLISM; THROMBOGENICITY; TRANSPLANTATION; UPREGULATION;

ADOLESCENT; ADULT; AGED; BLOOD COAGULATION TESTS; BLOOD PLATELETS; FEMALE; FLOW CYTOMETRY; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; PLATELET FUNCTION TESTS; THROMBOEMBOLISM;

EID: 4544288721     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAT.0000136515.97686.A2     Document Type: Article

References (39)

1. Oz MC, Argenziano M, Catanese Ka, et al: Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation? Circulation 95: 1844-1852, 1997.
2. Farrar DJ, Holman WR, Mc Bride LR, et al: Long-term follow-up of thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 21: 516-521, 2002.
3. Spanier T, Oz MC, Levin H, et al: Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. J Thorac Cardiovasc Surg 112: 1090-1097, 1996.
4. Loebe M, Koster A, Saenger S, et al: Inflammatory response after implantation of a left ventricular assist device: Comparison between the axial flow MicroMed DeBakey VAD and the pulsatile Novacor device. ASAIO J 47: 272-274, 2001.
5. Himmelreich G, Ullmann H, Riess H, et al: Pathophysiologic role of contact activation in bleeding followed by thromboembolic complications after implantation of a ventricular assist device. ASAIO J 41: M790-M794, 1995.
6. Livingston ER, Fisher CA, Bibidakis EJ, et al: Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation 94(9 Suppl): II227-II234, 1996.
7. Slater JP, Rose EA, Levin HR, et al: Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. Ann Thorac Surg 62: 1321-1327, 1996.
8. Pae WE: Ventricular assist devices and total artificial hearts: a combined registry experience. Ann Thorac Surg 55: 295-298, 1993.
9. Wieselthaler GM, Schima H, Hiesmayr M, et al: First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation. Circulation 101: 356-359, 2000.
10. Noon GP, Morley DL, Irwin S, et al: Clinical experience with the MicroMed DeBakey ventricular assist device. Ann Thorac Surg 71(3 Suppl): 5133-5138, 2001.
11. McBride LR, Naunheim KS, Fiore AC et al: Risk analysis in patients bridged to transplantation. Ann Thorac Surg 71: 1839-1844, 2001.
12. Wieselthaler GM, Schima H, Dworschak M, et al: First experiences with outpatient care of patients with implanted axial flow pumps. Artif Organs 25: 331-335, 2001.
13. DeBakey ME, Benkowski R: The DeBakey/NASA axial flow ventricular assist device, in Akutsu T, Koyanagi H (eds.), Heart Replacement and Artificial Heart Tokyo: Springer-Verlag. 407-413, 1998.
14. Schreiner W, Mueller MR, Premauer W, et al: Computerized acquisition and evaluation of whole blood aggregometry data. Comput Biol Med 21: 435-441, 1991.
15. Mueller MR, Salat A, Pulaki S, et al: Influence of hematocrit and platelet count on impedance and reactivity of whole blood for electrical aggregometry. J Pharmacol Toxicol Methods 34: 17-22, 1995.
16. Mueller MR, Schreiner W, Wohlfahrt A, et al: The influence of sample age on collagen-induced platelet aggregation in whole blood. Thromb Res 60: 477-487, 1990.
17. Salat A, Bodingbauer G, Boehm D, et al: Changes of platelet surface antigens in patients suffering from abdominal septic shock. Thromb Res 95: 289-294, 1999.
18. Schmitz G, Rothe G, Ruf A, et al: European working group on clinical analysis: Consensus protocol for the flowcytometric characterisation of platelet function. J Thromb Haemost 79: 885-896, 1998.
19. DeBakey ME: A miniature implantable axial flow ventricular assist device. Ann Thorac Surg 68: 637-640, 1999.
20. Jafri SM, Ozawa T, Mammen E, et al: Platelet function, thrombin and fibrinolytic activity in patients with heart failure. Eur Heart J 14: 205-212, 1993.
21. Jafri SM: Hypercoagulability in heart failure. Semin Thromb Hemost 23: 543-545, 1997.
22. Piccione W: Left ventricular assist device implantation: Short and long-term surgical complications. J Heart Lung Transplant 19: S89-S94, 2000.
23. Bozzo J, Hernandez MR, Ordinas A: Reduced red cell deformability associated with blood flow and platelet activation: Improved by dipyridamole alone or combined with aspirin. Cardiovasc Res 30: 725-730, 1995.
24. Mackie IJ, Jones R, Machin SJ: Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs. J Clin Pathol 37: 874-878, 1994.
25. Gum PA, Kottke-Marchant K, Poggio ED, et al: Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 88: 230-235, 2001.
26. Szefner J: Control and treatment of hemostasis in cardiovascular surgery. Int J Artif Organs 18: 633-648, 1995.
27. Michelson AD: Flow cytometry: A clinical test of platelet function. Blood 87: 4925-4936, 1996.
28. Jafri SM: Hypercoagulability in heart failure. Semin Thromb Hemost 23: 543-545, 1997.
29. Koster A, Loebe M, Hansen R, et al: Alterations in coagulation after implantation of a pulsatile Novacor LVAD and the axial flow MicroMed DeBakey LVAD. Ann Thorac Surg 70: 533-537, 2000.
30. Dewald O, Fischlein T, Vetter HO, et al: Platelet morphology in patients with mechanical circulatory support. Eur J Cardiothorac Surg 12: 634-641, 1997.
31. Wahba A, Lodes H, Barlage S, et al: Effects of extracorporeal circulation and heparin on the phenotype of platelet surface antigens following heart surgery. Thromb Res 97: 379-386, 2000.
32. Kawahito K, Mohara J, Misawa Y, et al: Platelet damage caused by the centrifugal pump: In vitro evaluation by measuring the release of alpha-granule packing proteins. Artif Organs 21: 1105-1109, 1997.
33. Ankersmit HJ, Wieselthaler G, Moser B, et al: Transitory immunologic response after implantation of the DeBakey VAD continuous-axial-flow pump. J Thorac Cardiovasc Surg 123: 557-561, 2002.
34. Snyder T, Watach MJ, Litwak KN, et al: Platelet activation, aggregation, and life span in calves implanted with axial flow ventricular assist devices. Ann Thorac Surg 73: 1933-1938, 2002.
35. Glauber M, Szefner J, Senni M, et al: Reduction of haemorrhagic complications during mechanically assisted circulation with the use of a multi-system anticoagulation protocol. Int J Artif Organs 18: 649-655, 1995.
36. Xiao Z, Théroux P: Platelet activation with unfractionated Heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation 97: 251-256, 1998.
37. Slater JP, Rose EA, Levin HR, et al: Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. Ann Thorac Surg 62: 1321-1328, 1996.
38. Ankersmit J, Schuster M, Hoffmann M, et al: Polymeric biomaterials act as superantigens, causing T-cell apoptosis via induction of CD95 ligand expression and defects in cellular immunity (abstract). Circulation 100 (Suppl): 1-802, 1999.
39. Koster A, Sanger S, Hansen R, et al: Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devices. ASAIO J 46: 319-322, 2000.